These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 9864077
21. Evaluation of thyroid function in lithium-naive bipolar patients. Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso-Mateos JL. Eur Psychiatry; 1999 Oct; 14(6):341-5. PubMed ID: 10572366 [Abstract] [Full Text] [Related]
22. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. Frye MA, Altshuler LL, Szuba MP, Finch NN, Mintz J. J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542 [Abstract] [Full Text] [Related]
23. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. Baethge C, Baldessarini RJ, Mathiske-Schmidt K, Hennen J, Berghöfer A, Müller-Oerlinghausen B, Bschor T, Adli M, Bauer M. J Clin Psychiatry; 2005 Feb; 66(2):174-82. PubMed ID: 15705002 [Abstract] [Full Text] [Related]
24. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination. Kishimoto A. Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):483-93. PubMed ID: 1641493 [Abstract] [Full Text] [Related]
25. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. J Affect Disord; 1999 Jul; 52(1-3):135-44. PubMed ID: 10357026 [Abstract] [Full Text] [Related]
26. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842 [Abstract] [Full Text] [Related]
27. Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T. Eur Arch Psychiatry Clin Neurosci; 1997 Feb 01; 247(1):42-50. PubMed ID: 9088805 [Abstract] [Full Text] [Related]
28. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. Post RM, Ketter TA, Uhde T, Ballenger JC. CNS Drugs; 2007 Feb 01; 21(1):47-71. PubMed ID: 17190529 [Abstract] [Full Text] [Related]
29. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. Bipolar Disord; 2001 Apr 01; 3(2):63-7. PubMed ID: 11333064 [Abstract] [Full Text] [Related]
30. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM. Cochrane Database Syst Rev; 2001 Apr 01; (3):CD003196. PubMed ID: 11687047 [Abstract] [Full Text] [Related]
31. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study. Musetti L, Tundo A, Benedetti A, Massimetti G, Cambiali E, Pergentini I, Del Grande C, Dell'Osso L. Hum Psychopharmacol; 2018 Nov 01; 33(6):e2676. PubMed ID: 30311959 [Abstract] [Full Text] [Related]
32. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D, Leverich GS, Post RM. Am J Psychiatry; 1999 Dec 01; 156(12):1909-14. PubMed ID: 10588404 [Abstract] [Full Text] [Related]
33. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants. Fawcett J, Kravitz HM. J Clin Psychiatry; 1985 Feb 01; 46(2):58-60. PubMed ID: 3968046 [Abstract] [Full Text] [Related]
34. Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Strömgren LS, Boller S. Psychiatr Dev; 1985 Feb 01; 3(4):349-67. PubMed ID: 3912763 [Abstract] [Full Text] [Related]
35. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. Ketter TA, Kalali AH, Weisler RH, SPD417 Study Group. J Clin Psychiatry; 2004 May 01; 65(5):668-73. PubMed ID: 15163253 [Abstract] [Full Text] [Related]
37. The increasing use of anticonvulsants in prophylactic treatment of bipolar disorder. Yang YY, Deng HC, Wang BH. Psychiatry Clin Neurosci; 1998 Aug 15; 52(4):429-31. PubMed ID: 9766693 [Abstract] [Full Text] [Related]
38. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness. Shukla S, Cook BL, Miller MG. J Affect Disord; 1985 Nov 15; 9(3):219-22. PubMed ID: 2867109 [Abstract] [Full Text] [Related]
39. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. Revicki DA, Hirschfeld RM, Ahearn EP, Weisler RH, Palmer C, Keck PE. J Affect Disord; 2005 Jun 15; 86(2-3):183-93. PubMed ID: 15935238 [Abstract] [Full Text] [Related]
40. Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophlyactic effectiveness. Bocchetta A, Chillotti C, Severino G, Ardau R, Del Zompo M. J Clin Psychopharmacol; 1997 Apr 15; 17(2):92-6. PubMed ID: 10950470 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]